Methylprednisolone Acetate (Injection) bulk supplier for pharma manufacturers

Methylprednisolone Acetate (Injection) Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 40 mg/mL, 80 mg/mL, 125 mg/2 mL

Reference Brands: Depo-Medrol(US)

Category: Arthritis

Methylprednisolone acetate injection is a corticosteroid that suppresses inflammation by reducing immune response and inflammatory gene expression. It provides rapid relief for severe flare-ups, joint pain, and swelling. Benefits include targeted, fast-acting anti-inflammatory effects, improved joint mobility, and effective long-term disease management when used under medical supervision.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Methylprednisolone Acetate (Injection)? List it or send an offer →

Product Description: Methylprednisolone acetate injection is approved in the EU and US for severe inflammatory and autoimmune conditions. In the EU, brands like Solu-Medrol are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on extensive clinical data. Both regions require detailed dossiers for approval and continuous pharmacovigilance. We streamline global market access for methylprednisolone acetate injections, ensuring adherence to European and American standards for safe, effective corticosteroid therapy, helping you navigate complex regulatory landscapes seamlessly.

Methylprednisolone Acetate (Injection) — third party manufacturing & bulk supply

Methylprednisolone Acetate (Injection) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Methylprednisolone Acetate (Injection) is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Methylprednisolone Acetate (Injection) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Methylprednisolone Acetate (Injection) →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Methylprednisolone Acetate (Injection) is listed as Injection in 40 mg/mL, 80 mg/mL, 125 mg/2 mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Methylprednisolone Acetate (Injection) is referenced against Depo-Medrol(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.